Navigation Links
New Vaccine May Offer Protection From Deadly Nipah Virus
Date:8/8/2012

WEDNESDAY, Aug. 8 (HealthDay News) -- A new vaccine developed by a team of researchers may protect people and livestock from the deadly Nipah virus.

The virus, upon which the Hollywood blockbuster Contagion was modeled, is found naturally in several species of fruit bats. Once infected, it causes serious respiratory distress syndrome and encephalitis. The researchers noted that in more than 75 percent of cases, those infected with Nipah die.

The researchers, led by Dr. Heinz Feldmann, chief of the Rocky Mountain Laboratories' Laboratory of Virology, conducted their research on live Nipah virus in a high-security facility in Hamilton, Mont.

They found that immunizing African green monkeys with a vaccine based on the Hendra virus attachment G glycoprotein completely protected them against Nipah virus infection.

"There are currently no approved vaccines for prevention of infection and disease caused by Nipah and Hendra for use by people or livestock," corresponding author Christopher Broder, a professor of microbiology at the Uniformed Services University in Bethesda, Md., said in a university news release. "This Hendra-sG vaccine has now been shown to be fully effective against infection by both Nipah and Hendra virus in at least three animal species, demonstrating its potential as a safe and effective vaccine, as a possible livestock vaccine and now also as possible vaccine for use in people."

The U.S. National Institutes of Health and U.S. Centers for Disease Control and Prevention both classify the Nipah virus and the Hendra virus as biothreat agents.

The Hendra-sG vaccine is produced in the laboratory using molecular techniques, the study authors noted.

"Since the vaccine is only a recombinant piece of the virus, it can be produced by itself and purified. [It] is a type of vaccine known as a subunit, thus making it extremely safe to use," study lead author Katharine Bossart, assistant professor in the department of microbiology at Boston University School of Medicine, said in a news release. Bossart developed the vaccine while at Uniformed Services University.

"This work now provides key evidence that a simple and safe recombinant vaccine against Nipah virus is possible," study co-author Thomas Geisbert, professor in the department of microbiology and immunology at the University of Texas Medical Branch and the Galveston National Laboratory, said in the news release. "Demonstrating this in a nonhuman primate model is a major step forward in developing it for future therapeutic use in people."

The findings were published online Aug. 8 in the journal Science Translational Medicine. Although the vaccine was successful in animal studies, results may be different in humans.

More information

The World Health Organization provides more information on Nipah virus.

-- Mary Elizabeth Dallas

SOURCE: Uniformed Services University of the Health Sciences, news release, Aug. 8, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. CDC Preparing Vaccine for New Swine Flu
2. Poor Sleep Hampers Vaccine Effectiveness: Study
3. Is Improved Vaccine Causing Whooping Cough Outbreaks?
4. Sleep affects potency of vaccines
5. NIDA supports development of combined anti-heroin and HIV vaccine
6. Scientists explore new class of synthetic vaccines
7. Mount Sinai researchers discover new target for vaccine development in abundant immune cells
8. Researchers study vaccine as potential weapon against aggressive brain tumors
9. Duke receives new grant for AIDS vaccine research
10. Parental consent for HPV vaccine should not be waived, poll says
11. Antibodies for new rotavirus vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Vaccine May Offer Protection From Deadly Nipah Virus
(Date:2/26/2017)... CA (PRWEB) , ... February 26, 2017 , ... NuevaCare, ... cities as diverse as Millbrae, Belmont, and Palo Alto, is proud to announce an ... Many Bay Area consumers look for home care close to home, and by having ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today it will ... the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace ... analytics to improve Medicaid population health management. , ODH will also have an exhibit ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... February 24, 2017 , ... With millions ... so critically important that we all are aware of our options and are ... proud to announce the launch of its newest edition of "Vision and Hearing" ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017   Royal Philips ... a global leader in health technology, today announced ... Administration (FDA) to market its ElastQ Imaging capability, ... of ultrasound systems. ElastQ Imaging enables simultaneous imaging ... is essential for the diagnosis of various liver ...
(Date:2/27/2017)... --  Vitasome ® Labs , Inc. has launched ... new liposome technology. Whereas vitamins lose on average between ... Physician,s Desk Reference , Vitasome , s ® ... and are scientifically formulated to: ... Improve bioavailability with a vastly higher absorption rate ...
(Date:2/27/2017)... WASHINGTON, Pa. , Feb. 27, 2017  Impax Laboratories, Inc. (NASDAQ: ... following upcoming investor conferences. Raymond James ... ET on March 6, 2017 in Orlando, FL. ... Conference at 8:00 a.m. ET on March 7, 2017 in ... 8:30 a.m.ET on March 16, 2017 in Miami, FL. ...
Breaking Medicine Technology: